Literature DB >> 4318814

The incidence of complement-fixing antibody to varicella-zoster virus in hospital patients and blood donors.

A H Tomlinson, F O MacCallum.   

Abstract

The sera of 308 patients, not suffering from varicella or zoster infections, and the sera of 183 blood donors were examined for complement-fixing antibody to varicella-zoster virus. In both groups about 70% of sera from persons aged 11-40 years had antibody titres >/= 1/4; the incidence was less in the age range 41-60 years and increased in later decades. Antibody titres of 1/16 or 1/32 were noticeably less frequent in those aged 41-60 years than in younger or older groups.It was concluded that an unchanging titre of 1/16 or 1/32 was of no diagnostic significance. The age distribution of antibody was consistent with the theory that zoster only occurs when antibody has declined.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4318814      PMCID: PMC2130815          DOI: 10.1017/s0022172400042315

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  9 in total

1.  A COMPLEMENT-FIXING ANTIGEN FOR VARICELLA-ZOSTER DERIVED FROM INFECTED CULTURES OF HUMAN FETAL DIPLOID CELLS.

Authors:  N J SCHMIDT; E H LENNETTE; C W SHON; T T SHINOMOTO
Journal:  Proc Soc Exp Biol Med       Date:  1964-05

2.  THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS.

Authors:  R E HOPE-SIMPSON
Journal:  Proc R Soc Med       Date:  1965-01

3.  POSSIBLE ANTIGENIC RELATIONSHIP BETWEEN VARICELLA ZOSTER VIRUS AND HERPES SIMPLEX VIRUS.

Authors:  J G KAPSENBERG
Journal:  Arch Gesamte Virusforsch       Date:  1964-09-09

4.  Immunological relationship between herpes simplex and varicella-zoster viruses demonstrated by complement-fixation, neutralization and fluorescent antibody tests.

Authors:  N J Schmidt; E H Lennette; R L Magoffin
Journal:  J Gen Virol       Date:  1969-04       Impact factor: 3.891

5.  The incidence of Herpesvirus hominis antibody in the population.

Authors:  I W Smith; J F Peutherer; F O MacCallum
Journal:  J Hyg (Lond)       Date:  1967-09

6.  Varicella virus in HeLa cells.

Authors:  A Svedmyr
Journal:  Arch Gesamte Virusforsch       Date:  1965

7.  Neutralization tests with varicella-zoster virus.

Authors:  A E Caunt; D G Shaw
Journal:  J Hyg (Lond)       Date:  1969-06

8.  Immunofluorescent staining in the laboratory diagnosis of varicella-zoster virus infections.

Authors:  N J Schmidt; E H Lennette; J D Woodie; H H Ho
Journal:  J Lab Clin Med       Date:  1965-09

9.  Antigenic relationship of varicella-zoster and herpes simplex.

Authors:  C A Ross; J H Subak Sharpe; P Ferry
Journal:  Lancet       Date:  1965-10-09       Impact factor: 79.321

  9 in total
  4 in total

1.  Quantitation of antibodies to varicella-zoster virus by immune adherence hemagglutination.

Authors:  C L Wong; S Castriciano; M A Chernesky; W E Rawls
Journal:  J Clin Microbiol       Date:  1978-01       Impact factor: 5.948

2.  Outbreak of chickenpox from a patient with immunosuppressed herpes zoster in hospital.

Authors:  R Faizallah; H T Green; N Krasner; R J Walker
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-09

3.  Social epidemiology of chickenpox in two British national cohorts.

Authors:  J I Pollock; J Golding
Journal:  J Epidemiol Community Health       Date:  1993-08       Impact factor: 3.710

4.  Age-specific prevalence of complement-fixing antibodies to sixteen viral antigens: a computer analysis of 58,500 patients covering a period of eight years.

Authors:  P Ukkonen; T Hovi; C H von Bonsdorff; P Saikku; K Penttinen
Journal:  J Med Virol       Date:  1984       Impact factor: 2.327

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.